======= RNF113A ======= == Gene Information == * **Official Symbol**: RNF113A * **Official Name**: ring finger protein 113A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7737|7737]] * **UniProt**: [[https://www.uniprot.org/uniprot/O15541|O15541]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RNF113A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RNF113A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300951|Open OMIM]] == Function Summary == * **Entrez Summary**: This intronless gene encodes a protein which contains a C3H1-type zinc finger domain and a C3HC4 Ring-type (Really Interesting New Gene-type) zinc finger domain. The Ring-type zinc finger domain is identified in various tumor suppressors, DNA repair genes and cytokine receptor-associated molecules, and is probably involved in mediating protein-protein interactions. [provided by RefSeq, May 2010]. * **UniProt Summary**: N/A |zf-CCCH| |isopeptide cross-linking via N6-glycyl-L-lysine| |snoRNA splicing| |isopeptide cross-linking| |peptidyl-glycine modification| |negative regulation of chemokine-mediated signaling pathway| |U2-type spliceosomal complex| |regulation of chemokine-mediated signaling pathway| |snoRNA processing| |snoRNA metabolic process| |U2-type precatalytic spliceosome| |peptide cross-linking| |negative regulation of cytokine-mediated signaling pathway| |negative regulation of response to cytokine stimulus| |regulation of cytokine-mediated signaling pathway| |regulation of response to cytokine stimulus| |ubiquitin-protein transferase activity| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |RNA splicing, via transesterification reactions| |peptidyl-lysine modification| |ncRNA processing| |RNA splicing| |nuclear speck| |ncRNA metabolic process| |mRNA processing| |DNA repair| |protein ubiquitination| |mRNA metabolic process| |DNA metabolic process| |protein modification by small protein conjugation| |cellular response to DNA damage stimulus| |RNA processing| |peptidyl-amino acid modification| |protein modification by small protein conjugation or removal| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of response to stimulus| |RNA metabolic process| |cellular response to stress| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp443|SNS-032 15μM R08 exp443]]|-2.61| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|-2.43| |[[:results:exp19|Etoposide 1μM R00 exp19]]|-2.4| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|-1.96| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.83| |[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|1.71| |[[:results:exp262|Alda-1 10μM R06 exp262]]|1.77| |[[:results:exp504|MK2206 4μM R08 exp504]]|1.83| |[[:results:exp132|Metformin 40μM R03 exp132]]|1.88| |[[:results:exp49|NFN1 0.1μM R01 exp49]]|1.95| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|2.01| |[[:results:exp145|PNU96415E 10μM R03 exp145]]|2.04| |[[:results:exp185|L-BMAA 500 to 750μM on day4 R04 exp185]]|2.11| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|2.19| |[[:results:exp155|UNC1999 2μM R03 exp155]]|2.24| ^Gene^Correlation^ |[[:human genes:z:znf148|ZNF148]]|0.51| |[[:human genes:t:tceb3c|TCEB3C]]|0.5| |[[:human genes:r:rbm39|RBM39]]|0.494| |[[:human genes:i:ints5|INTS5]]|0.494| |[[:human genes:p:psmb4|PSMB4]]|0.485| |[[:human genes:r:rps2|RPS2]]|0.484| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.481| |[[:human genes:r:rpl35|RPL35]]|0.479| |[[:human genes:s:slc6a17|SLC6A17]]|0.477| |[[:human genes:t:tceb3cl|TCEB3CL]]|0.475| |[[:human genes:p:prim1|PRIM1]]|0.47| |[[:human genes:h:hgc6.3|HGC6.3]]|0.47| |[[:human genes:c:cactin|CACTIN]]|0.469| |[[:human genes:m:myo1h|MYO1H]]|0.465| |[[:human genes:p:psma6|PSMA6]]|0.463| |[[:human genes:s:sart1|SART1]]|0.46| |[[:human genes:n:narfl|NARFL]]|0.45| |[[:human genes:t:ticrr|TICRR]]|0.446| |[[:human genes:d:ddtl|DDTL]]|0.446| |[[:human genes:g:golga8o|GOLGA8O]]|0.445| |[[:human genes:c:cep192|CEP192]]|0.444| |[[:human genes:i:iscu|ISCU]]|0.444| |[[:human genes:s:sf3a3|SF3A3]]|0.439| |[[:human genes:s:snip1|SNIP1]]|0.436| |[[:human genes:c:chd4|CHD4]]|0.436| |[[:human genes:g:golga6l3|GOLGA6L3]]|0.432| |[[:human genes:r:rps3a|RPS3A]]|0.431| |[[:human genes:e:eif3g|EIF3G]]|0.431| |[[:human genes:z:zfand5|ZFAND5]]|0.429| |[[:human genes:p:psmd14|PSMD14]]|0.428| |[[:human genes:d:dtl|DTL]]|0.427| |[[:human genes:t:tbc1d3h|TBC1D3H]]|0.426| |[[:human genes:c:copg1|COPG1]]|0.425| |[[:human genes:r:rps12|RPS12]]|0.424| |[[:human genes:o:orc1|ORC1]]|0.424| |[[:human genes:t:tp53tg3d|TP53TG3D]]|0.424| |[[:human genes:c:cdc73|CDC73]]|0.423| |[[:human genes:k:kctd17|KCTD17]]|0.423| |[[:human genes:w:wdr75|WDR75]]|0.422| |[[:human genes:s:sf3a1|SF3A1]]|0.421| |[[:human genes:t:tp53tg3b|TP53TG3B]]|0.421| |[[:human genes:t:tp53tg3c|TP53TG3C]]|0.421| |[[:human genes:a:atp6v1c1|ATP6V1C1]]|0.42| |[[:human genes:p:psmd1|PSMD1]]|0.42| |[[:human genes:t:tp53tg3|TP53TG3]]|0.42| |[[:human genes:d:dhx38|DHX38]]|0.42| |[[:human genes:t:twistnb|TWISTNB]]|0.419| |[[:human genes:r:rpa2|RPA2]]|0.418| |[[:human genes:r:rrp15|RRP15]]|0.417| |[[:human genes:c:ccdc94|CCDC94]]|0.417| |[[:human genes:a:atp6v0b|ATP6V0B]]|0.416| |[[:human genes:d:dido1|DIDO1]]|0.416| |[[:human genes:e:exd1|EXD1]]|0.415| |[[:human genes:p:psmb2|PSMB2]]|0.415| |[[:human genes:c:c14orf93|C14orf93]]|0.414| |[[:human genes:s:setd1a|SETD1A]]|0.413| |[[:human genes:b:bysl|BYSL]]|0.412| |[[:human genes:o:orc6|ORC6]]|0.412| |[[:human genes:c:cdc6|CDC6]]|0.411| |[[:human genes:p:pola2|POLA2]]|0.41| |[[:human genes:a:akirin2|AKIRIN2]]|0.41| |[[:human genes:a:aqr|AQR]]|0.409| |[[:human genes:v:vasn|VASN]]|0.409| |[[:human genes:r:rpl34|RPL34]]|0.407| |[[:human genes:i:ints6|INTS6]]|0.407| |[[:human genes:r:rrp7a|RRP7A]]|0.406| |[[:human genes:c:copa|COPA]]|0.404| |[[:human genes:c:ccna2|CCNA2]]|0.404| |[[:human genes:k:kiaa0947|KIAA0947]]|0.403| |[[:human genes:d:dand5|DAND5]]|0.403| |[[:human genes:l:lrr1|LRR1]]|0.403| |[[:human genes:m:mdm2|MDM2]]|0.402| |[[:human genes:a:apc2|APC2]]|0.402| |[[:human genes:e:eif4a3|EIF4A3]]|0.402| |[[:human genes:n:nol10|NOL10]]|0.401| |[[:human genes:w:wdr87|WDR87]]|0.401| |[[:human genes:n:nbpf10|NBPF10]]|0.4| |[[:human genes:r:rbbp5|RBBP5]]|0.4| Global Fraction of Cell Lines Where Essential: 535/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|22/28| |blood|23/26| |bone|20/26| |breast|24/30| |central nervous system|36/49| |cervix|1/4| |colorectal|13/17| |esophagus|7/11| |fibroblast|0/1| |gastric|13/14| |kidney|12/18| |liver|11/19| |lung|52/72| |lymphocyte|15/16| |ovary|20/25| |pancreas|14/22| |peripheral nervous system|11/15| |plasma cell|7/12| |prostate|1/1| |skin|16/20| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|14/22| |urinary tract|24/28| |uterus|4/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1613 * **Expression level (log2 read counts)**: 4.37 {{:chemogenomics:nalm6 dist.png?nolink |}}